Chemours reports Q1 2026 net loss of $29M but sees strong sales growth in refrigerants and plans debt reduction.

Chemours reported a net loss of $29 million in Q1 2026, compared to a $5 million loss in the prior year, mainly due to higher financing and administrative costs. Despite this, the company achieved a 1% increase in net sales to $1.4 billion, driven by record growth in its Thermal & Specialized Solutions segment, especially in Opteon™ and Freon™ refrigerants. Chemours also received $287 million from selling part of its Kuan Yin property, enabling debt repayment and improving liquidity. The company expects Q2 sales to rise 15-20% sequentially and projects full-year sales growth of 3-5%, with ongoing focus on flexible strategies and cost improvements.